AKTX vs CSX · $17.2M cap vs P/E 19, rev $7.42B
Akari Therapeutics PLC (AKTX) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
CSX Corporation (CSX) is a railroads company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
AKTX currently screens at market cap $17.2M. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the AKTX and CSX stock pages for the full models.
Not investment advice.